Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.042 SGD | +2.44% | +5.00% | -6.67% |
12/03 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
12/03 | IX Biopharma Introduces New Sublingual Wafer | MT |
Sales 2022 | 14.39M 10.56M 881M | Sales 2023 | 5.91M 4.34M 362M | Capitalization | 69.73M 51.18M 4.27B |
---|---|---|---|---|---|
Net income 2022 | -4M -2.94M -245M | Net income 2023 | -9M -6.61M -551M | EV / Sales 2022 | 7.87 x |
Net cash position 2022 | 9.18M 6.74M 562M | Net cash position 2023 | 2.2M 1.61M 134M | EV / Sales 2023 | 11.4 x |
P/E ratio 2022 |
-26.3
x | P/E ratio 2023 |
-7.22
x | Employees | 45 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.01% |
1 day | +2.44% | ||
1 week | +5.00% | ||
Current month | -19.23% | ||
1 month | -20.75% | ||
3 months | -2.33% | ||
6 months | +5.00% | ||
Current year | -6.67% |
Managers | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 08/04/08 |
Sien Lup Chew
DFI | Director of Finance/CFO | 60 | 14/16/14 |
Chief Operating Officer | 45 | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 08/04/08 |
Shing Tung Ho
BRD | Director/Board Member | 57 | 01/13/01 |
Patrick Davies
BRD | Director/Board Member | 57 | 02/19/02 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.042 | +2.44% | 20,000 |
25/24/25 | 0.041 | -4.65% | 179,900 |
22/24/22 | 0.043 | +7.50% | 196,900 |
19/24/19 | 0.04 | -11.11% | 189,600 |
Delayed Quote Singapore S.E., April 26, 2024 at 12:44 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 23.68M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 42C Stock